Postsurgical chylothorax after lung resection has an important associated rate of morbidity and mortality, and a large proportion of cases require re-exploration. The most desirable and least aggressive option is conservative treatment. The use of octreotide seems to be associated with a higher rate of resolution without the need for surgical intervention. We present 4 cases in which this drug showed excellent efficacy and minimal adverse effects in the resolution of postsurgical chylothorax.
Get full access to this article
View all access options for this article.
References
1.
FahimiHCasselmanFPMarianiMAvan BovenWJKnaepenPJvan SwietenHA. Current management of postoperative chylothorax. Ann Thorac Surg2001;71:448–51.
2.
RimensbergerPCMuller-SchenkerBKalangosABeghettiM. Treatment of a persistent postoperative chylothorax with somatostatin. Ann Thorac Surg1998;66:253–4.
3.
KellyRFShumwaySJ. Conservative management of postoperative chylothorax using somatostatin. Ann Thorac Surg2000;69:1944–5.
4.
VallieresEShamjiFMToddTR. Postpneumonectomy chylothorax. Ann Thorac Surg1993;55:1006–8.
5.
PratapUSlavikZOfoeVDOnuzoOFranklinRC. Octreotide to treat postoperative chylothorax after cardiac operations in children. Ann Thorac Surg2001;72:1740–2.
6.
WolffABSilenMLKokoskaERRodgersBM. Treatment of refractory chylothorax with externalized pleuroperitoneal shunts in children. Ann Thorac Surg1999;68:1053–7.
7.
Le CoultreCOberhansliIMossazABugmannPFaiduttiBBelliDC. Postoperative chylothorax in children: Differences between vascular and traumatic origin. J Pediatr Surg1991;26:519–23.
